Cutaneous Metastasis of Ovarian Tumor after Hysterectomy and Bilateral Salpingo-oophorectomy: A Case Report
DOI:
https://doi.org/10.37762/jgmds.11-3.599Keywords:
Ovarian Tumor, Hysterectomy, Salpingi-OophorectomyAbstract
OBJECTIVES
Cutaneous metastases are a very rare presentation of ovarian tumors (OV). They occur in about 3.5 percent of cases. The prognosis of cutaneous metastases is not good despite recent treatment modalities. Researchers are looking for much more personalized treatments. The patient had a history of ovarian tumor, for which she had a hysterectomy and bilateral salpingo-oophorectomy. She presented with multiple cutaneous eruptions. The histopathology shows high-grade serous carcinoma of the ovaries. Immunochemistry is positive for cytokeratin 7, WT1, and CAX. She had developed left leg swelling, generalized edema, and complaints of dysuria and difficulty defecating. Many targeted therapies have been developed, such as inhibiting growth factor receptors and immunological treatments that induce cell death, opening the door to precision medicine.
Downloads
Metrics
References
McDonald HH, Moore MR, Meffert JJ. Cutaneous metastases from adenocarcinoma of the ovary. JAAD Case Reports. 2016 Sep;2(5):406-7. DOI: https://doi.org/10.1016/j.jdcr.2016.08.010
Otsuka. Cutaneous Metastases in Ovarian Cancer. Cancers. 2019 Sep 2;11(9):1292. DOI: https://doi.org/10.3390/cancers11091292
Li J, Cao C, Liu P, Yan Z, Xing D, Liu A. Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature. Diagnostic Pathology. 2022 Oct 5;17(1). DOI: https://doi.org/10.1186/s13000-022-01256-x
Ramos A, Theisen E, Duncan LM, Filipi J, Kao Y, Yeku OO. Three Cases of Atypical Cutaneous Ovarian Metastases: A Single-Center Case Series. Annals of Internal Medicine: Clinical Cases. 2022 Nov 1;1(9 DOI: https://doi.org/10.7326/aimcc.2022.0541
Narod S. Can advanced-stage ovarian cancer be cured? Nature Reviews Clinical Oncology. 2016 Jan 20;13(4):255-61. DOI: https://doi.org/10.1038/nrclinonc.2015.224
Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K. Epidemiology of ovarian cancer. Chinese Clinical Oncology. 2020 Aug;9(4):47-47. DOI: https://doi.org/10.21037/cco-20-34
Meinhold-Heerlein I, Fotopoulou C, Harter P, Kurzeder C, Mustea A, Wimberger P, et al. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Archives of Gynecology and Obstetrics. 2016 Feb 19;293(4):695-700. DOI: https://doi.org/10.1007/s00404-016-4035-8
Otsuka I. Cutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible Mechanisms. International Journal of Molecular Sciences. 2019 Jul 4;20(13):3286. DOI: https://doi.org/10.3390/ijms20133286
Trimbos JB. Surgical treatment of early-stage ovarian cancer. Best Practice & Research Clinical Obstetrics & Gynaecology. 2017 May;41:60-70. DOI: https://doi.org/10.1016/j.bpobgyn.2016.10.001
Mei L, Chen H, Wei DM, Fang F, Liu GJ, Xie HY, et al. Maintenance chemotherapy for ovarian cancer. Cochrane Database of Systematic Reviews. 2013 Jun 29;2022(1). DOI: https://doi.org/10.1002/14651858.CD007414.pub3
Akter S, Rahman MdA, Hasan MN, Akhter H, Noor P, Islam R, et al. Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements. Cells. 2022 Feb 13;11(4):650. DOI: https://doi.org/10.3390/cells11040650
Wan C, Keany MP, Dong H, Al-Alem LF, Pandya UM, Lazo S, et al. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Cancer Research. 2021 Jan 1;81(1):158-73 DOI: https://doi.org/10.1158/0008-5472.CAN-20-1674
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hamid Naeem, Qazi Muhammad Farooq Wahab, Junaid Imran, Mazhar Khalil
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
